Jamie Michele Olejarski, MD
Endocrinology, Diabetes & Metabolism Physician · Temple, TX
Jamie Michele Olejarski, MD is an endocrinology, diabetes & metabolism physician with a practice address in Temple, Texas, and NPI 1134470198, issued on Sep 30, 2012. Check the license (Texas P3400, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Jamie Michele Olejarski
- Credential
- MD
- Primary taxonomy
- Endocrinology, Diabetes & Metabolism Physician 207RE0101X
- License number
- P3400 TX
Self-reported in NPPES; status is on the state search - Practice location
- 2401 S 31St St, Temple, TX 76508
- Phone
- (254) 724-2111
- Enumerated
- Sep 30, 2012
- Record last updated
- Jan 6, 2021 (not updated in 5 years: call before relying on the address or phone)
- Medicare enrollment
- Enrolled (PECOS I20140917000454); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest endocrinology, diabetes & metabolism physician records → All 743 in Texas → Look up another NPI →
Also registered at 2401 S 31St St
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Qamar Abbas, DOInternal Medicine Physician1063090967
- Stephen Abernathy, M.D.Surgery Physician1851389779
- Ossama Abou HassanCardiovascular Disease Physician1083252332
- Jose Marri Abril, MDSurgery Physician1336620806
- Kellie Achord, PA-CPhysician Assistant1841754355
- Alisa Acosta, MD, MPHPediatric Nephrology Physician1053553214
Verify Jamie Michele Olejarski in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license P3400Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
60% more Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024
4,195 Medicare Part D claims for 677 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 58% of claims.
Most prescribed
- Mounjaro486 claims
- Levothyroxine Sodium422 claims
- Ozempic376 claims
- Metformin Hcl Er225 claims
- Jardiance208 claims
- Alendronate Sodium152 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Bills Medicare through one group practice
- Scott And White ClinicTemple, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Jamie Michele Olejarski among 743 endocrinology, diabetes & metabolism physician records in Texas
Jamie Michele Olejarski, MD is one of 743 endocrinology, diabetes & metabolism physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2012, is newer than 69% of them.
- NPI issued2012 · 69% of these records are older, 27% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 75% of these records are
- Graduated2009 · median 2004 among the 560 with a school on file
- Record last updated2021 · 50% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Endocrinology, Diabetes & Metabolism Physician providers in Texas
There are 743 endocrinology, diabetes & metabolism physician records in Texas.
All 743 in Texas → Every provider in Temple → Endocrinology, Diabetes & Metabolism Physician nationwide →
The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes
- Mohini Bollineni, M.B,B.STemple, TX 765081659641355
- Sabita Challagulla, M.DTemple, TX 765081336337229
- Gary Chune, M.D.Temple, TX 765081184684169
- Anthony Cryar, M.D.Temple, TX 765081790745651
- Ashley Doucet, DOTemple, TX 765081205492352
- Prashant Nadkarni, M.D.Temple, TX 765081861455750
- Edward Nicklas, MDTemple, TX 765081639138605
- Veronica Piziak, M.D.Temple, TX 765081851352223
Common questions
What is Jamie Michele Olejarski, MD's NPI number?
Jamie Michele Olejarski, MD's National Provider Identifier (NPI) is 1134470198, issued on Sep 30, 2012. An NPI identifies a provider in billing; it is not a license.
Where is Jamie Michele Olejarski, MD located?
The NPPES record lists a practice address at 2401 S 31St St, Temple, TX, 76508. Phone: (254) 724-2111. Providers update this record themselves, so call before visiting.
How can I verify Jamie Michele Olejarski, MD's license?
NPPES lists Texas license number P3400, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Jamie Michele Olejarski, MD prescribe under Medicare Part D?
In 2024, Jamie Michele Olejarski, MD had 4,195 Medicare Part D claims for 677 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.